Skip to main content

28 March 2023

Last updated: Sunday 26 March 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Investment pendulum swings back towards biotech

Friday 20 January 2012

Interviewee/Contributor

Bart Bergstein

Organisation

Forbion Capital Partners

Organisations

MedCity
Mission Therapeutics
Forbion
Results Healthcare
BioLizard NV
Aravis Venture
ERA Consulting Group
Allergy Therapeutics Plc
MedNous contributing editor
OxStem Ltd

Interviewees and Contributers

Ingrid Klingmann.
Michael Hunt
Werner Lanthaler
Madhusudan Peshwa
Bruno Pagliara
Dr Howard Fillit
Steven Powell
Andy Smith
Jennifer Cubino
Richard Goodfellow

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Medivir has new CMO

Sunday 19 March 2023

New advisory board member at Pan Cancer T

Sunday 19 March 2023

Osivax appoints Chris Martin to board

Sunday 19 March 2023

Two changes to Novo Nordisk executive team

Sunday 19 March 2023

New deputy director at the FDA

Sunday 19 March 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form